Drx Dly S&p Biotech Bear 3x
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 16 superinvestors own shares of Drx Dly S&p Biotech Bear 3x (LABD), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Drx Dly S&p Biotech Bear 3x (LABD), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Drx Dly S&p Biotech Bear 3x (LABD) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Drx Dly S&p Biotech Bear 3x (LABD) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
Superinvestor | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
Matthew Levine@Virtu Financial Llc
| 0.18% | $3.251M 556,650 shares@ 5.85 avg price | Decreased -34.44% |
Tien-Fu Liu@Jane Street Group, Llc
| 0.01% | $883,662 151,312 shares@ 5.84 avg price | Decreased -25.66% |
Debora L. Burrowes@Morgan Stanley
| 0.01% | $48,321 8,274 shares@ 5.85 avg price | Decreased -58.18% |
Ichiro Kajiwara@Paypay Securities Corp
| 0.31% | $3,469 594 shares@ 5.85 avg price | Decreased -65.32% |
Claire Jarrett@Qube Research & Technologies Ltd
| 0.01% | $2,546 436 shares@ 5.84 avg price | Decreased -66.56% |